Skip to main content
. 2012 Apr 24;72(2):229–234. doi: 10.1136/annrheumdis-2011-201108

Figure 2.

Figure 2

Hazard for soft tissue infections (SSI) and shingles over time in anti-tumour necrosis factor (TNF)-treated cohort. Demonstration of the time-varying risk of events in the anti-TNF cohort. Event rates were higher earlier on during treatment in both cohorts.